(Q57580742)

English

The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy

article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy (English)

0 references

1 reference

based on heuristic

inferred from title

intraepithelial neoplasia

1 reference

based on heuristic

inferred from title

object named as

Paolo Veronesi

4

0 references

Giuseppe Curigliano

object named as

Giuseppe Curigliano

5

0 references

Viviana Galimberti

3

object named as

Viviana Galimberti

0 references

Aron Goldhirsch

7

object named as

Aron Goldhirsch

0 references

Umberto Veronesi

8

object named as

Umberto Veronesi

0 references

author name string

Gabriel Farante

1

0 references

Stefano Zurrida

2

0 references

Alberto Luini

6

0 references

language of work or name

0 references

publication date

26 August 2010

0 references

Breast Cancer Research and Treatment

0 references

128

0 references

2

0 references

369-378

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Rethinking TNM: breast cancer TNM classification for treatment decision-making and research

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Trends in the treatment of ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

The management of ductal carcinoma in situ in North America and Europe. Results of a survey

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Patterns and correlates of local therapy for women with ductal carcinoma-in-situ

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Conservative management of intraductal carcinoma (DCIS) of the breast. Collaborating NSABP investigators

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Duct carcinoma in situ: 227 cases without microinvasion

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Ductal intraepithelial neoplasia: postsurgical outcome for 1,267 women cared for in one single institution over 10 years

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Ductal carcinoma in situ: state of the science and roadmap to advance the field

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Ductal carcinoma-in-situ: long-term results of breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

The influence of margin width on local control of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Radiological and pathological size estimations of pure ductal carcinoma in situ of the breast, specimen handling and the influence on the success of breast conservation surgery: a review of 2564 cases from the Sloane Project

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Ductal carcinoma in situ, complexities and challenges.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Heterogeneity of ductal carcinoma in situ and its effects on management

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Ductal carcinoma in situ: surgery and radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Current treatment and clinical trial developments for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Pathologic variables predictive of breast events in patients with ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margin status

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Sentinel node biopsy in ductal carcinoma in situ patients

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Is sentinel node biopsy necessary in conservatively treated DCIS?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

High and intermediate grade ductal carcinoma in-situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close or positive margin in the excision

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma and microinvasive carcinoma treated by mastectomy.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Tumour-positive sentinel node findings in patients with ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Prospective study of wide excision alone for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Ductal carcinoma in situ: role of the boost

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO).

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Are aromatase inhibitors superior to antiestrogens?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Prevention of hormone-related cancers: breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Effect of interleukin 12 on tumor induction by 3-methylcholanthrene

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Prevention of gastrointestinal tumors based on adenomatous polyposis coli gene mutation by dendritic cell vaccine

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Boost radiotherapy in young women with ductal carcinoma in situ: a multicentre, retrospective study of the Rare Cancer Network

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-1124-4

21 January 2018

Identifiers

10.1007/S10549-010-1124-4

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57580742&oldid=2213537262"